Crossmark

Does tocilizumab have an effect on the clinical outcomes in COVID-19 patients? A meta-analysis of randomized control trials

Crossref DOI link: https://doi.org/10.1186/s40545-023-00662-w

Published Online: 2024-03-11

Published Print: 2023-12-31

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Ghaempanah, Faezeh

Nikouei, Maziar

Cheraghi, Mojtaba

Jahangiri, Arman

Moradi, Yousef https://orcid.org/0000-0002-2936-5930
License Information

Version of Record valid from 2023-12-31
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=jppp20

Publication History

Received: 2023-01-19

Accepted: 2023-11-14

Published: 2024-03-11